Initial investigation and information gathering. CMA analysis and review of information gathered.
The following changes have been made to the case timetable since it was first published in October 2017:
Date of change
Reason for change
Change made to timetable
19 April 2018
Additional time needed to gather and analyse additional information
Date for completing initial investigation and information gathering changed from April 2018 to June 2018
On 10 October 2017, the CMA launched an investigation under Chapter I of the CA98 and Article 101 of the TFEU into suspected breaches of competition law by various parties. The investigation relates to alleged anti-competitive agreements and/or concerted practices in relation to generic pharmaceutical products.
The CMA has not reached a view on whether there is sufficient evidence of an infringement of competition law for it to issue a statement of objections to the parties under investigation. Not all cases result in the CMA issuing a statement of objections.